학술논문

Use of an antiplatelet monoclonal antibody Fab'2fragment for imaging thrombus
Document Type
Article
Source
Nuclear Medicine Communications; September 1988, Vol. 9 Issue: 9 p647-656, 10p
Subject
Language
ISSN
01433636; 14735628
Abstract
Ten patients with suspected thrombus have been studied using 111in-labelled F(ab')2fragments of P256, a monoclonal antibody which recognizes an epitope on the platelet membrane glycoprotein Ilb/IIIa complex. The F(ab')2fragment was radiolabelled with 111In via diethylenetriaminepenta-acetic acid to give a specific activity of up to 190 MBq (5 mCi) mg−1without impairment of immunoreactivity. In vitroplatelet aggregation studies showed that the F(ab')2fragment caused less platelet aggregation than the whole antibody on a molar ratio and was without significant effect upon the sensitivity of platelets to a range of aggregating agents. Platelets were labelled in ten patients by intravenous injection of approximately 100 (μg P256 F(ab')2. Of the ten patients studied, six showed localization of activity consistent with platelet accumulation. Localization was clearly seen when associated with thrombus of the lower limbs (three patients: deep vein thrombosis; one patient: aortofemoral graft), and was apparent although less marked in two other cases, one of aortic aneurysm and one of carotid stenosis. Use of radiolabelled P256 F(ab')2offers a means of non-invasive detection of thrombus which, from in vitrostudies, would appear to have less direct effect on platelet behaviour than the whole antibody.